506414 — Fermenta Biotech Share Price
0.000.00%
Last trade - 00:00- IN₹6.62bn
- IN₹7.37bn
- IN₹3.36bn
- 86
- 31
- 87
- 81
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.7 | ||
| Price to Tang. Book | 1.77 | ||
| Price to Free Cashflow | 5.69 | ||
| Price to Sales | 1.46 | ||
| EV to EBITDA | 28.12 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1.24% | ||
| Return on Equity | -7.64% | ||
| Operating Margin | -1.38% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 2,929.49 | 3,772.89 | 3,985.16 | 3,499.44 | 3,356.62 | n/a | n/a | -3.67% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -67.23 | +17.46 | -66.12 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. The Company's segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. The Company has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and rodenticides. The Company provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, natural astaxanthin and vitamin AD2 premix, among others.
Directors
- Sanjay Buch NEC
- Govind Desai NEC
- Prashant Nagre CEO
- Krishna Datla VCH (38)
- Keshav Kashid CFO
- Srikant Sharma CCO
- Rajeshwari Datla NED (63)
- Satish Varma NED (43)
- Vinayak Hajare NID (53)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- May 1st, 1951
- Public Since
- January 4th, 1990
- No. of Employees
- 550
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 28,874,200
- Address
- A -1601, THANE, 400610
- Web
- https://fermentabiotech.com/
- Phone
- +91 2267980888
- Contact
- Srikant Sharma
- Auditors
- SRBC & Co LLP
Upcoming Events for 506414
Fermenta Biotech Ltd Annual Shareholders Meeting
Q2 2025 Fermenta Biotech Ltd Earnings Release
Similar to 506414
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
Ambalal Sarabhai Enterprises
Bombay Stock Exchange
FAQ
What is the Fermenta Biotech share price?
As of Today at 14:39 UTC, shares in Fermenta Biotech are trading at IN₹169.85. This share price information is delayed by 15 minutes.
How has the Fermenta Biotech share price performed this year?
Shares in Fermenta Biotech last closed at IN₹169.85 and the price had moved by +24.71% over the past 365 days. In terms of relative price strength the Fermenta Biotech share price has underperformed the S&P BSE 100 Index by -4.71% over the past year.
What are the analyst and broker recommendations for Fermenta Biotech?
The overall consensus recommendation for Fermenta Biotech is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Fermenta Biotech dividend yield?
The Fermenta Biotech dividend yield is 0.74% based on the trailing twelve month period.
Does Fermenta Biotech pay a dividend?
Last year, Fermenta Biotech paid a total dividend of IN₹1.25, and it currently has a trailing dividend yield of 0.74%. We do not have any data on when Fermenta Biotech is to next pay dividends.
When does Fermenta Biotech next pay dividends?
We do not have data on when Fermenta Biotech is to next pay dividends. The historic dividend yield on Fermenta Biotech shares is currently 0.74%.
How do I buy Fermenta Biotech shares?
To buy shares in Fermenta Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Fermenta Biotech?
As of the previous close price of IN₹169.85, shares in Fermenta Biotech had a market capitalisation of IN₹4.90bn.
Where are Fermenta Biotech shares listed?
Here are the trading details for Fermenta Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 506414
What kind of share is Fermenta Biotech?
Based on an overall assessment of its quality, value and momentum Fermenta Biotech is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Fermenta Biotech share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Fermenta Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fermenta Biotech. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -6.02%.
As of the last closing price of IN₹169.85, shares in Fermenta Biotech were trading +2.99% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Fermenta Biotech PE Ratio?
The Fermenta Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹169.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Fermenta Biotech?
Fermenta Biotech's management team is headed by:
- Sanjay Buch - NEC
- Govind Desai - NEC
- Prashant Nagre - CEO
- Krishna Datla - VCH
- Keshav Kashid - CFO
- Srikant Sharma - CCO
- Rajeshwari Datla - NED
- Satish Varma - NED
- Vinayak Hajare - NID